<--- Back to Details
First PageDocument Content
Granulocytes / Immunology / Glycoproteins / Basophil activation / CD63 / Immunoglobulin E / Basophil granulocyte / Allergy / CD23 / Biology / Cell biology / Immune system
Granulocytes
Immunology
Glycoproteins
Basophil activation
CD63
Immunoglobulin E
Basophil granulocyte
Allergy
CD23
Biology
Cell biology
Immune system

Clinical and Molecular Allergy BioMed Central Open Access

Add to Reading List

Source URL: www.clinicalmolecularallergy.com

Download Document from Source Website

File Size: 1,93 MB

Share Document on Facebook

Similar Documents

Medicine / Immunology / Immune system / Clinical medicine / Omalizumab / Immunoglobulin E / Allergen / Plasmacytoid dendritic cell / Allergy / Immunogen / TLR9 / Dendritic cell

Curing Allergic Diseases S-TARget therapeutics GmbH Mooslackengasse 17, 1190 Vienna, Austria. Phone:+, +, +Confidential

DocID: 1rgTJ - View Document

Medicine / Anatomy / Clinical medicine / Autoimmune diseases / Autoimmunity / Systemic lupus erythematosus / Immunology / Lupus erythematosus / Baxter International / Immunoglobulin E

SuppreMol_Crawford Release ENG_Mar 4, 2015

DocID: 1qGKf - View Document

Medicine / Immunology / Clinical medicine / Food allergies / Immune system / Allergology / RTT / Allergy / Milk allergy / Immunoglobulin E / Phadia / Allergen

Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor &alpha; antibody, in a phase I study of patients with mild asthma

DocID: 1qDqa - View Document

Foreign relations / Law / Government / Antibodies / Glycoproteins / Immune system / Immunoglobulin E / Swiss Federal Institute of Intellectual Property / FTO / Patent infringement / Patent Cooperation Treaty / Intellectual property

KASCHE & PARTNER AG INTELLECTUAL PROPERTY Dr. André Kasche Dr. Oliver Horlacher

DocID: 1qxAK - View Document

Medicine / Immunology / Clinical medicine / Immune system / Allergology / Glycoproteins / Monoclonal antibodies / Omalizumab / Immunoglobulin E / Asthma / Allergic conjunctivitis / Allergen

Validation of Peptide Immunotherapy as a New Approach in the Treatment of Allergic Rhinoconjunctivitis: The Clinical Benefits of Treatment with Amb a 1 Derived T cell Epitopes

DocID: 1qs00 - View Document